[Skip to Content]
[Skip to Content Landing]
January 18, 2006

Medical Student Exposure to Drug Company Interactions

Author Affiliations

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295(3):281-282. doi:10.1001/jama.295.3.281-a

To the Editor: I believe that the study on medical student exposure to drug company interactions by Dr Sierles and colleagues1 came to the wrong conclusions. I recognize the need to protect naive students from pharmaceutical marketing that may lead to unrecognized influence on their choices of therapeutic agents. However, it seems duplicitous to criticize students for receiving gifts when they see their mentors giving lectures, doing research, and traveling using pharmaceutical money. Students are encouraged to read high-quality medical journals, which contain many advertisements for some of the most expensive pharmaceuticals currently marketed (including the issue of JAMA in which this study was published).